LifeSteps Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

LifeSteps Financial’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.4K	Buy	+36	New	+$24.5K	0.01%	295

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

LifeSteps Financial's REGN Position: Q2 2026 in Review

LifeSteps Financial opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 36 shares worth $22.4K. The stake represents 0.01% of the portfolio and ranks #295 among its holdings.

481 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

LifeSteps Financial held 36 shares of Regeneron Pharmaceuticals worth $22.4K as of Q2 2026.
Regeneron Pharmaceuticals was a new LifeSteps Financial position in Q2 2026.
Regeneron Pharmaceuticals made up 0.01% of LifeSteps Financial's portfolio in Q2 2026, its #295 holding.
481 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.